Go Back

Company or ticker...

Alkermes

Alkermes develops and sells medicines for neurological and psychiatric disorders, including schizophrenia and bipolar disorder.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

ALKS

8.0B

4.4

n/a

69.87%

Key Facts

M. Cap

PS

PE

YTD

8.0B

4.4

n/a

69.87%

10MA

20MA

50MA

200MA

$ALKS

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now